Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KV Pharmaceutical Enters Into Amendment Agreement With Hologic
Upon approval by the FDA, Gestiva will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single
Upon approval by the FDA, Gestiva will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single
The manufacturing facility is now ready to offer contract manufacturing services which could commence following the manufacture of Multikine. Reportedly, the phase III clinical trial with Multikine will
Under the terms of agreement, Qiagen is expected to provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities and staff to
Diagnostic Hybrids, based in Athens, Ohio, manufactures in vitro diagnostic assays used in hospital and reference laboratories for a variety of diseases, including viral respiratory infections, herpes, chlamydia
Pfizer and Debiopharm have entered into a co-development agreement to conduct a phase 3 trial of Tremelimumab (CP675,206), a fully human anti-CTLA4 monoclonal antibody, for the treatment of
Varlix, with expertise in neuro and spine surgery, has been introducing medical devices and capital equipment to the Mexican surgical marketplace on a regular basis. Misonix said that
The Cystinosis Research Foundation (CRF) of Irvine, California, has awarded $1.75m in 11 new grants to researchers in the US, Canada, Belgium and Italy, who are working to
Chennai-based Orchid Chemicals & Pharmaceuticals has received atentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (NDA) for Memantine Hydrochloride tablets
Transgene Bioteck (TBL) has signed a licensing and technology transfer agreement with Dr. Reddy’s Laboratories (DRL), Hyderabad, for the out licensing of a technology to be used for
3SBio, a company focused on research, development, manufacturing and marketing of biopharmaceutical products primarily in China, has submitted its application for a registrational clinical trial to the Chinese